Results 351 to 360 of about 219,417 (396)

Serum CDC42 level change during abiraterone plus prednisone treatment and its association with prognosis in metastatic castration-resistant prostate cancer patients. [PDF]

Discov Oncol
Ma Y, Cao Z, Zhang J, Zhu X, Zhao Z, Xiong J.   +5 more
europepmc   +1 more source

Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer. [PDF]

Cancer
Fukuokaya W, Mori K, Yanagisawa T, Urabe F, Rajwa P, Briganti A, Shariat SF, Matsubara N, Kimura T, Hirakawa A.   +9 more
europepmc   +1 more source

The effect of lyophilised oral faecal microbial transplantation on functional outcomes in dogs with diabetes mellitus

Journal of Small Animal Practice, EarlyView.
Objectives We aimed to determine if oral faecal microbiota transplantation improves indices of glycaemic control, changes the faecal dysbiosis indices, alters faecal short‐chain fatty acid and bile acid profiles and increases serum glucagon‐like‐peptide 1 concentrations in diabetic dogs.
R. Brown, P. Barko, J. D. J. Ruiz Romero, D. A. Williams, A. Gochenauer, J. Nguyen‐Edquilang, J. S. Suchodolski, R. Pilla, H. Ganz, N. Lopez‐Villalobos, A. Gal   +10 more
wiley   +1 more source

Utilization of patient-reported outcomes to assess adherence to relugolix when combined with stereotactic body radiation therapy for intermediate to high-risk prostate cancer. [PDF]

Front Oncol
Gaudian K, Koh MJ, Koh MJ, Collins RR, Eden S, Zwart Z, Danner M, Zwart A, Fallick M, Kumar D, Leger P, Dawson NA, Suy S, Collins SP.   +13 more
europepmc   +1 more source

Immunohistochemical Analysis of Androgen Receptor Expression Predicts the Prognosis of Metastatic Castration-Sensitive Prostate Cancer Patients Receiving Abiraterone Acetate. [PDF]

Prostate
Nishimoto M, De Velasco MA, Yamamoto Y, Fujimoto S, Akashi Y, Toyoda S, Hashimoto M, Adomi S, Banno E, Saito Y, Minami T, Hirayama A, Yoshimura K, Uemura H, Fujita K.   +14 more
europepmc   +1 more source

Pathologic response as an early endpoint for survival following neoadjuvant androgen deprivation therapy plus abiraterone acetate for metastatic prostate cancer. [PDF]

Eur J Med Res
Zhou K, Lu H, Wei F, Wang J, Song Z, Mao L.   +5 more
europepmc   +1 more source

Castration-Resistant Prostate Cancer Presenting as Bulky Lymphadenopathy: A Case without Bone Metastasis. [PDF]

Am J Case Rep
Yadav R, Huang S, Uche I, Pokhrel A, Zahid U, Mooppan U, Wang JC.   +6 more
europepmc   +1 more source

Cabazitaxel-induced ureteritis in metastatic castration-resistant prostate cancer patients: a single center case series 2014-2024. [PDF]

Cancer Imaging
Zedan AH, Gade JS, Zieger KEA, Poulsen MH, Vejlgaard AS, Fredensborg FLH.   +5 more
europepmc   +1 more source

EphB4-ephrin-B2 are targets in castration resistant prostate cancer. [PDF]

Br J Cancer
Li GX, Ma B, Zhang S, Liu R, Siddiqi IN, Sali A, El-Khoueiry A, Gross M, Salhia B, Sadeghi S, Gill PS.   +10 more
europepmc   +1 more source